Updated:
Tianjin Venture Capital
Tianjin Venture Capital is a venture capital firm based in China, focusing on investments in information technology, new energy, and the biomedical sectors.
Tianjin Venture Capital
Tianjin Venture Capital is a venture capital firm based in China, focusing on investments in information technology, new energy, and the biomedical sectors. The firm has made 100 investments, including a Series A investment in Shiqi Biochemical on February 28, 2026. Tianjin Venture Capital has facilitated 12 portfolio exits, with Axera exiting on February 10, 2026.
General information
Firm type
Venture Capital
Year founded
2000
Location
Region
Asia
Country
China
City
Tianjin
Corporate office
Tianjin, China
Sector focus
Frequently asked questions
How is Tianjin Venture Capital structured — is it a fund or a direct investment vehicle?
TVC operates as a limited liability company directly capitalized by the Tianjin municipal government, not as a GP-LP fund structure. It deploys balance-sheet capital into equity positions across seed, venture, expansion, and pre-IPO stages. This makes it a direct investor with a policy mandate, rather than a fund manager raising discretionary commitments from third-party institutional LPs.
What is TVC's relationship to the Tianjin municipal government?
TVC was established by the Tianjin government as a state-guided equity investment platform. Its capital base derives from municipal fiscal allocations, and its investment priorities align with Tianjin's five-year economic development plans. The firm is subject to state audit oversight, and its strategic direction reflects local industrial policy objectives rather than purely commercial return targets.
What sectors and stages does TVC target?
TVC covers a venture-to-growth spectrum spanning seed, start-up, expansion, and pre-IPO investments. Sector focus tracks Tianjin's industrial strengths and national strategic priorities — enterprise software, industrial automation, clean energy, new energy vehicles, advanced manufacturing, and biopharmaceuticals. The firm frequently anchors rounds in companies with research ties to Tianjin-based institutions.
Does TVC co-invest alongside commercial venture capital firms?
Yes — TVC routinely co-invests alongside other provincial government guidance funds, state-owned enterprises, and selected commercial venture firms. Its position as a local policy investor frequently makes it an anchor or cornerstone investor in rounds where co-investors are brought in to fill out the syndicate, particularly for companies aligned with municipal technology transfer goals.
Does Tianjin Venture Capital disclose its assets under management?
No. TVC does not publicly disclose assets under management, aggregate deployment figures, or fund-level performance data. Its capital base reflects direct government allocations rather than fundraises, and reporting obligations are to state audit bodies rather than public markets or institutional limited partners.
Does TVC accept outside limited partners or institutional capital?
TVC is not structured as a fund manager raising capital from third-party institutional LPs. Its balance sheet is funded through municipal fiscal allocations. While it co-invests alongside other state and commercial entities, it does not operate as a traditional GP soliciting discretionary commitments from pension funds, endowments, or family offices.
Is TVC's investment activity concentrated geographically?
TVC concentrates deployment within China's Bohai Rim economic zone, with a heavy emphasis on the Tianjin-Binhai corridor. Its mandate prioritizes locally anchored companies and technology commercialization efforts linked to regional universities and research institutes, though it may participate in deals outside Tianjin when aligned with industrial policy objectives.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: